Cargando…
Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19
BACKGROUND: Venous thromboembolism (VTE) is a common complication in acute COVID-19 and those with hematologic malignancy (HM) may be at an even higher risk. We performed a retrospective analysis of patients with history of HM and acute COVID-19 to evaluate thrombotic and clinical outcomes. METHODS:...
Autores principales: | Cook, Michael R., Dykes, Kaitlyn, White, Katherine, Desale, Sameer, Agrawal, Rajeev, Fernandez, Stephen, Huang, Xu, Cobb, Nathan K., Lai, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710237/ https://www.ncbi.nlm.nih.gov/pubmed/35058217 http://dx.doi.org/10.1016/j.clml.2021.12.011 |
Ejemplares similares
-
Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19
por: Cook, Michael Roderick, et al.
Publicado: (2020) -
Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program
por: Tendas, Andrea, et al.
Publicado: (2011) -
Hematological Malignancies and Arterial Thromboembolism
por: Visweshwar, Nathan, et al.
Publicado: (2019) -
Atypical Presentation of Thrombotic Thrombocytopenic Purpura without Hematological Features
por: Singh, Balraj, et al.
Publicado: (2020) -
Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)